GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Other Income (Expense)

BeyondSpring (BeyondSpring) Other Income (Expense) : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Other Income (Expense)?

BeyondSpring's other income expense for the BeyondSpring's pretax income for the three months ended in Dec. 2023 was $0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


BeyondSpring Other Income (Expense) Historical Data

The historical data trend for BeyondSpring's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Other Income (Expense) Chart

BeyondSpring Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.36 1.59 0.94 0.85

BeyondSpring Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 - - - -

BeyondSpring Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BeyondSpring  (NAS:BYSI) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


BeyondSpring (BeyondSpring) Business Description

Traded in Other Exchanges
N/A
Address
28 Liberty Street, 39th Floor, New York, NY, USA, 10005
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

BeyondSpring (BeyondSpring) Headlines

From GuruFocus

BeyondSpring Files 2022 Annual Report on Form 20-F

By sperokesalga sperokesalga 04-18-2023

BeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Rules

By Stock market mentor Stock market mentor 01-09-2023